uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. Verksamhetsområde hematologi. (Blodsjukdomar)
2005 (English)In: Bone Marrow Transplant, ISSN 0268-3369, Vol. 35, no 10, 985-90 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 35, no 10, 985-90 p.
Keyword [en]
Adult, Aged, Female, Glomerular Filtration Rate, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cell Transplantation/*adverse effects, Humans, Iohexol/pharmacokinetics, Male, Melphalan/*administration & dosage, Middle Aged, Multiple Myeloma/mortality/physiopathology/*therapy, Retrospective Studies
Identifiers
URN: urn:nbn:se:uu:diva-78305PubMedID: 15806125OAI: oai:DiVA.org:uu-78305DiVA: diva2:106218
Available from: 2006-05-15 Created: 2006-05-15 Last updated: 2011-01-11

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15806125&dopt=Citation
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 492 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf